Publications by authors named "I Goljer"

Claim this Profile
T
The metabolism and disposition of GSK2140944 in healthy human subjects.
Kitaw Negash, Clara Andonian, Clive Felgate, Cathy Chen, Igor Goljer

Xenobiotica· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, pharmacokinetics, and antiviral activity of GSK2336805, an inhibitor of hepatitis C virus (HCV) NS5A, in healthy subjects and subjects chronically infected with HCV genotype 1.
D A Wilfret, J Walker, K K Adkison, L A Jones, Y Lou, I Goljer

Antimicrob Agents Chemother· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism, excretion, and mass balance of the HIV-1 integrase inhibitor dolutegravir in humans.
Stephen Castellino, Lee Moss, David Wagner, Julie Borland, Ivy Song, Igor Goljer

Antimicrob Agents Chemother· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism of intravenous methylnaltrexone in mice, rats, dogs, and humans.
Appavu Chandrasekaran, Zeen Tong, Hongshan Li, John C L Erve, William DeMaio, Igor Goljer

Drug Metab Dispos· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of phenylsulfone-substituted quinoxaline (WYE-672) as a tissue selective liver X-receptor (LXR) agonist.
Baihua Hu, Rayomand J Unwalla, Igor Goljer, James W Jetter, Elaine M Quinet

J Med Chem· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis